Commenting on the state of the UK life sciences ecosystem in a keynote address to the Bioindustry Association (BIA) UK Bioscience Forum in London BIA CEO Steve Bates OBE, will say: “The UK life sciences ecosystem is in a fantastic place. I see innovation, opportunity and collaboration everywhere. We are in an era of profound scientific opportunity.”
The opening address will cover key issues that are currently having an impact on the UK bioscience ecosystem including government funding, Brexit, R&D development, the NHS and the future of the European Medicines Agency (EMA).
The UK BioIndustry Association (BIA) has today launched a series of four explainer booklets and five videos that celebrate the fantastic work taking place in UK bioscience companies to create innovative new drugs and treatments for patients.
Global outsourcing leader Scientist.com to deliver Faster ScienceTM to BIA members throughout the UK
SAN DIEGO & LONDON, DATE (BUSINESS WIRE) - Scientist.com, the world’s largest marketplace for outsourced scientific services, today announced a partnership with the BioIndustry Association (BIA), the UK’s national trade association for innovative bioscience enterprises. The partnership will allow BIA members to access the Scientist.com marketplace, connect with global experts and purchase custom research services required for drug R&D.
The UK BioIndustry Association (BIA) and Informa Pharma Intelligence have today released the Biotech Financing Update June - August 2018 that shows that UK biotech companies have already raised more than £1.5 billion in 2018, surpassing the 2017 annual total of £1.2 billion.
The UK BioIndustry Association (BIA) and the Medicines and Healthcare products Regulatory Agency (MHRA) brought together experts from across the life sciences sector to discuss some hot topics and important developments through a series of presentations and panel discussions.
Commenting on NICE and NHS England’s decision to fund Novartis’ Kymriah for patients up to 25 years old with a certain type of leukemia, BIA CEO, Steve Bates, said:
“Today’s decisions by NICE NHS England shows that the UK is well set to be the best country in the world in which to invent, trial, develop, manufacture and market next generation CAR-T cell cancer therapies.
The Department of Health has today written to pharmaceutical companies on the EU Exit – Human medicines supply in a March 2019 ‘no deal’ scenario. The letter details government contingency plans to stockpile medicines to cope with any potential delays at the border that may arise in the short term.
The UK Government has today released a series of 25 technical notices that offer guidance for business on what will happen in a ‘no deal’ Brexit. The notices were launched following a speech by Brexit Secretary Dominic Raab.